Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Liver Diseases

  Free Subscription


11.06.2018

2 Am J Gastroenterol
2 Am J Pathol
1 Ann Intern Med
2 Biochem Biophys Res Commun
2 BMC Cancer
1 BMC Gastroenterol
1 Cancer Res
2 Dig Dis Sci
1 Endoscopy
1 Eur Radiol
2 Gastroenterology
1 Gastrointest Endosc
1 Hepatology
1 Int J Cancer
7 J Gastroenterol Hepatol
5 J Hepatol
1 J Pediatr Surg
2 Lancet
2 Lancet Oncol
1 Oncogene
1 Radiology
2 Semin Liver Dis


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Gastroenterol

  1. BAJAJ JS, Acharya C, Fagan A, White MB, et al
    Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in Cirrhosis.
    Am J Gastroenterol. 2018 Jun 6. pii: 10.1038/s41395-018-0085.
    PubMed     Text format     Abstract available

  2. LAI JC, Tandon P
    How I Approach It: Improving Nutritional Status in Patients With Cirrhosis.
    Am J Gastroenterol. 2018 Jun 5. pii: 10.1038/s41395-018-0080.
    PubMed     Text format    


    Am J Pathol

  3. DUARTE S, Matian P, Ma S, Busuttil RW, et al
    Adeno-Associated Virus-Mediated Gene Transfer of Tissue Inhibitor of Metalloproteinases-1 Impairs Neutrophil Extracellular Trap Formation and Ameliorates Hepatic Ischemia and Reperfusion Injury.
    Am J Pathol. 2018 Jun 2. pii: S0002-9440(18)30029.
    PubMed     Text format     Abstract available

  4. WANG J, Kainrad N, Shen H, Zhou Z, et al
    Hepatic Knockdown of Splicing Regulator Slu7 Ameliorates Inflammation and Attenuates Liver Injury in Ethanol-Fed Mice.
    Am J Pathol. 2018 Jun 2. pii: S0002-9440(18)30158.
    PubMed     Text format     Abstract available


    Ann Intern Med

  5. HAGHIGHAT L, Brandt EJ, Proctor DD, Garcia-Tsao G, et al
    Evolution of Intrahepatic Shunts in a Patient With Hereditary Hemorrhagic Telangiectasia.
    Ann Intern Med. 2018 Jun 5. pii: 2683644. doi: 10.7326/L18-0036.
    PubMed     Text format    


    Biochem Biophys Res Commun

  6. FAN XD, Zheng HB, Fan XS, Lu S, et al
    Increase of SOX9 promotes hepatic ischemia/reperfusion (IR) injury by activating TGF-beta1.
    Biochem Biophys Res Commun. 2018 Jun 4. pii: S0006-291X(18)31311.
    PubMed     Text format     Abstract available

  7. XUE X, Wang X, Zhao Y, Hu R, et al
    Exosomal miR-93 promotes proliferation and invasion in hepatocellular carcinoma by directly inhibiting TIMP2/TP53INP1/CDKN1A.
    Biochem Biophys Res Commun. 2018 Jun 4. pii: S0006-291X(18)31299.
    PubMed     Text format     Abstract available


    BMC Cancer

  8. NG L, Chow AKM, Man JHW, Yau TCC, et al
    Suppression of Slit3 induces tumor proliferation and chemoresistance in hepatocellular carcinoma through activation of GSK3beta/beta-catenin pathway.
    BMC Cancer. 2018;18:621.
    PubMed     Text format     Abstract available

  9. HATOOKA M, Kawaoka T, Aikata H, Inagaki Y, et al
    Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial.
    BMC Cancer. 2018;18:633.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  10. MARMUR J, Beshara S, Eggertsen G, Onelov L, et al
    Hepcidin levels correlate to liver iron content, but not steatohepatitis, in non-alcoholic fatty liver disease.
    BMC Gastroenterol. 2018;18:78.
    PubMed     Text format     Abstract available


    Cancer Res

  11. HILL MA, Alexander WB, Guo B, Kato Y, et al
    Kras and Tp53 mutations cause cholangiocyte- and hepatocyte-derived cholangiocarcinoma.
    Cancer Res. 2018 Jun 5. pii: 0008-5472.CAN-17-1123.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  12. KOK B, Lester ELW, Lee WM, Hanje AJ, et al
    Acute Liver Failure from Tumor Necrosis Factor-alpha Antagonists: Report of Four Cases and Literature Review.
    Dig Dis Sci. 2018;63:1654-1666.
    PubMed     Text format     Abstract available

  13. TSIAOUSSIS GI, Papaioannou EC, Kourea EP, Assimakopoulos SF, et al
    Expression of alpha-Defensins, CD20+ B-lymphocytes, and Intraepithelial CD3+ T-lymphocytes in the Intestinal Mucosa of Patients with Liver Cirrhosis: Emerging Mediators of Intestinal Barrier Function.
    Dig Dis Sci. 2018 Jun 7. pii: 10.1007/s10620-018-5146.
    PubMed     Text format     Abstract available


    Endoscopy

  14. OGURA T, Okuda A, Miyano A, Kamiyama R, et al
    Double intrahepatic bile duct puncture: a pitfall during endoscopic ultrasound-guided hepaticogastrostomy.
    Endoscopy. 2018 Jun 7. doi: 10.1055/a-0605-2710.
    PubMed     Text format    


    Eur Radiol

  15. SONG J, Ma Z, Huang J, Liu S, et al
    Comparison of three cut-offs to diagnose clinically significant portal hypertension by liver stiffness in chronic viral liver diseases: a meta-analysis.
    Eur Radiol. 2018 Jun 1. pii: 10.1007/s00330-018-5478.
    PubMed     Text format     Abstract available


    Gastroenterology

  16. CHUNG HH
    The Multiple Modulation of miR-122 in the Attenuation of Alcoholic Liver Disease.
    Gastroenterology. 2018;154:1857.
    PubMed     Text format    

  17. GUILLAUME M, Bureau C
    Should the Presence of Spontaneous Portosystemic Shunts Be Implemented to the Model for End-Stage Liver Disease Score for a Better Prediction of Outcome?
    Gastroenterology. 2018;154:1569-1571.
    PubMed     Text format    


    Gastrointest Endosc

  18. OH D, Seo DW, Hong SM, Jun JH, et al
    The usefulness of contrast-enhanced harmonic EUS-guided fine-needle aspiration for evaluation of hepatic lesions (with video).
    Gastrointest Endosc. 2018 May 31. pii: S0016-5107(18)32751.
    PubMed     Text format     Abstract available


    Hepatology

  19. RUSSO N, Brown RS Jr, Cohen-Mekelburg S, Schwartz RE, et al
    Hepatology Highlights.
    Hepatology. 2018;67:2065-2067.
    PubMed     Text format    


    Int J Cancer

  20. ARAI J, Goto K, Tanoue Y, Ito S, et al
    Enzymatic inhibition of MICA sheddase ADAM17 by lomofungin in hepatocellular carcinoma cells.
    Int J Cancer. 2018 Jun 6. doi: 10.1002/ijc.31615.
    PubMed     Text format     Abstract available


    J Gastroenterol Hepatol

  21. LIU T, Xu L, Wang C, Chen K, et al
    Shikonin alleviates hepatic fibrosis and autophagy via inhibition of TGF-beta1/Smads pathway.
    J Gastroenterol Hepatol. 2018 Jun 4. doi: 10.1111/jgh.14299.
    PubMed     Text format     Abstract available

  22. DONG XQ, Li J, Liu H, Wang YW, et al
    Hepatobiliary and Pancreatic: A rare cause of decompensated liver cirrhosis.
    J Gastroenterol Hepatol. 2018 Jun 3. doi: 10.1111/jgh.14273.
    PubMed     Text format    

  23. MATSUI N, Imajo K, Yoneda M, Kessoku T, et al
    Magnetic resonance elastography increases usefulness and safety of non-invasive screening for esophageal varices.
    J Gastroenterol Hepatol. 2018 Jun 4. doi: 10.1111/jgh.14298.
    PubMed     Text format     Abstract available

  24. MANNAMI T, Fujiwara N, Ikeda G, Ebara H, et al
    Hepatobiliary and Pancreatic: A pancreatic stone causing biliary obstruction through major papillary impaction.
    J Gastroenterol Hepatol. 2018;33:1166.
    PubMed     Text format    

  25. LIN YX, Fu YY, Cui T, Jia QB, et al
    Hepatobiliary and Pancreatic: Alpha fetoprotein producing distal cholangiocarcinoma metastasized to the ovary.
    J Gastroenterol Hepatol. 2018;33:1167.
    PubMed     Text format    

  26. DUAN X, Meng Q, Wang C, Liu Z, et al
    Effects of calycosin against high-fat diet-induced nonalcoholic fatty liver disease in mice.
    J Gastroenterol Hepatol. 2018;33:533-542.
    PubMed     Text format     Abstract available

  27. PARENTE DB, Oliveira Neto JA, Brasil PEAA, Paiva FF, et al
    Preperitoneal fat as a non-invasive marker of increased risk of severe non-alcoholic fatty liver disease in patients with type 2 diabetes.
    J Gastroenterol Hepatol. 2018;33:511-517.
    PubMed     Text format     Abstract available


    J Hepatol

  28. LEE S, Kang TW
    Reply to "Influence of ablation technique on treatment failure for perivascular hepatocellular carcinoma".
    J Hepatol. 2018 Jun 2. pii: S0168-8278(18)32117.
    PubMed     Text format    

  29. SUNDARAM V, Goldberg DS, Jalan R
    Author response: Is obesity a risk factor for the development of acute on chronic liver failure in patients with decompensated cirrhosis?
    J Hepatol. 2018 May 31. pii: S0168-8278(18)32100.
    PubMed     Text format    

  30. NAKAMURA K, Zhang M, Kageyama S, Ke B, et al
    Protective effects of heme oxygenase 1 during ischemia r epefrfsuion injury: Hepatocytes or non parenchymal cells?
    J Hepatol. 2018 Jun 2. pii: S0168-8278(18)32114.
    PubMed     Text format    

  31. SEGERITZ CP, Rashid ST, Cardoso de Brito M, Paola MS, et al
    hiPSC hepatocyte model demonstrates the role of unfolded protein response and inflammatory networks in alpha1-antitrypsin deficiency.
    J Hepatol. 2018 Jun 4. pii: S0168-8278(18)32113.
    PubMed     Text format     Abstract available

  32. TURCO L, Garcia-Tsao G, Rossi R, Villa E, et al
    Reply to "The Relationship of Hyperdynamic Circulation and Cardiodynamic States in Cirrhosis".
    J Hepatol. 2018 Jun 2. pii: S0168-8278(18)32101.
    PubMed     Text format    


    J Pediatr Surg

  33. HONG SK, Yi NJ, Chang H, Ahn SW, et al
    The rate of hepatic artery complications is higher in pediatric liver transplant recipients with metabolic liver diseases than with biliary atresia.
    J Pediatr Surg. 2018 Apr 27. pii: S0022-3468(18)30275.
    PubMed     Text format     Abstract available


    Lancet

  34. GARCIA-TSAO G
    Long-term albumin in cirrhosis: is it the ANSWER?
    Lancet. 2018 May 31. pii: S0140-6736(18)30948.
    PubMed     Text format    

  35. CARACENI P, Riggio O, Angeli P, Alessandria C, et al
    Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial.
    Lancet. 2018 May 31. pii: S0140-6736(18)30840.
    PubMed     Text format     Abstract available


    Lancet Oncol

  36. PERSONENI N, Rimassa L
    Shaping the landscape of immune oncology in hepatocellular carcinoma.
    Lancet Oncol. 2018 Jun 1. pii: S1470-2045(18)30383.
    PubMed     Text format    

  37. ZHU AX, Finn RS, Edeline J, Cattan S, et al
    Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial.
    Lancet Oncol. 2018 Jun 1. pii: S1470-2045(18)30351.
    PubMed     Text format     Abstract available


    Oncogene

  38. KANDA M, Tanaka H, Shimizu D, Miwa T, et al
    SYT7 acts as a driver of hepatic metastasis formation of gastric cancer cells.
    Oncogene. 2018 Jun 1. pii: 10.1038/s41388-018-0335.
    PubMed     Text format     Abstract available


    Radiology

  39. JOO I, Lee JM, Yoon JH
    Imaging Diagnosis of Intrahepatic and Perihilar Cholangiocarcinoma: Recent Advances and Challenges.
    Radiology. 2018 Jun 5:171187. doi: 10.1148/radiol.2018171187.
    PubMed     Text format     Abstract available


    Semin Liver Dis

  40. DOU L, Ono Y, Chen YF, Thomson AW, et al
    Hepatic Dendritic Cells, the Tolerogenic Liver Environment, and Liver Disease.
    Semin Liver Dis. 2018;38:170-180.
    PubMed     Text format     Abstract available

  41. RIMBAS M, Di Maurizio L, Rizzatti G, Gasbarrini A, et al
    Endoscopic Ultrasound for the Hepatologist: A Comprehensive Review.
    Semin Liver Dis. 2018;38:145-159.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: